VVOS Historical PE Ratio Notes

— Vivos Therapeutics ("VVOS") is a medical technology company specializing in the development & commercialization of innovative diagnostic & treatment solutions for patients suffering from sleep-disordered breathing, notably obstructive sleep apnea (OSA). VVOS offers a proprietary line of oral appliances that provide an alternative to traditional CPAP machines, positioning itself in an evolving healthcare landscape focused on patient comfort, accessibility, & physician-driven therapies. For an investor analyzing VVOS's historical price-to-earnings (P/E) ratio, it's essential to recognize that as an emerging growth company, Vivos has often posted losses or minimal earnings, which can result in an undefined, negative, or highly variable P/E ratio at many points in its history. Unlike mature companies with stable earnings, early-stage medtech firms like VVOS are typically valued by the market based more on growth potential, revenue trajectories, & the adoption of their technology, rather than consistent earnings. This context helps explain periods of no P/E or spikes in the ratio, reflecting investor sentiment around future profitability rather than stable historical earnings. When reviewing VVOS's historical P/E chart, these nuances should be kept in mind to avoid misinterpretations based solely on P/E fluctuations.

On this page we presented the VVOS Historical PE Ratio information for Vivos Therapeutics' stock. The average VVOS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VVOS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VVOS historical PE result, against the recent PE: when this page was posted on 6/11/2026, the most recent closing price for VVOS had been 0.61, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on VVOS or any other given stock, valuation analysis for VVOS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Vivos Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VVOS. Thanks for visiting, and the next time you need to research VVOS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.